Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Esophageal Cancer
Interventions
GENETIC

TNFerade

Trial Locations (12)

44106

University Hospitals of Cleveland, Cleveland

63110

St. Louis University, St Louis

75246

US Oncology, Mary Crowley Center, Dallas

75702

Tyler Cancer Center, Tyler

76508

Scott & White Center for Cancer Prevention and Care, Temple

92868

University of California, Irvine, Orange

94304

Palo Alto VA Health Care Systems, Palo Alto

92093-0064

UCSD Cancer Center, La Jolla

60637-1470

The University of Chicago Medical Center, Chicago

21231-2410

Johns Hopkins School of Medicine, Baltimore

77030-4009

University of Texas/MD Anderson, Houston

23298-0058

Medical College of Virginia, Richmond

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GenVec

INDUSTRY